Dream Analysis in COPD Patients
Rêve BPCO
1 other identifier
observational
61
1 country
1
Brief Summary
Sleep is a fundamental period in life. In a previous work, the investigators have shown that COPD patients presented on the EEG figures found in patients with chronic pain: Alpha-Delta. The link between dyspnea and pain is very strong and this Alpha-Delta could, in these COPD patients, be the witness of nocturnal dyspnea. Although it is not possible in a non-awake patient to evaluate reliably the dyspnea, sleep offers us a window on the emotions and the feeling of the patient: Dreams. A few studies have shown the link between breathing and dreaming, but none of them has focused on nocturnal dyspnea. Our working hypothesis is that respiratory abnormalities in COPD patients are responsible for nocturnal dyspnea, which is reflected in the content of these patients' dreams.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2022
CompletedFirst Posted
Study publicly available on registry
March 2, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedOctober 30, 2023
October 1, 2023
1.3 years
February 21, 2022
October 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the dreams reported by the patient during 15 days
analysis of the dream book filled in by the patient during 15 days
15 days after inclusion
Secondary Outcomes (2)
Typical Dream Questionnaire
to inclusion
HAD Scale
to inclusion
Study Arms (2)
COPD patients
Arm with patients with respiratory disease in whom we study dreams
healthy subject
Arm with healthy subjects whose dream analysis will be used as a basis to compare them to the dreams of COPD patients and see if the disease (COPD) has an influence on the patients' dreams
Interventions
Each of the dreams was classified according to its thematic content (e.g., being involved in a chase, flying through the air, falling, being lost, losing one's teeth, drowning) in order to in a chase, flying through the air, falling, being lost, losing teeth, drowning) in order to determine the most determine the most frequent themes emerging from our sample. The instrument used used to carry out this classification is the "Typical Dream Questionnaire" of Zadra and Nielsen (1999), which has been validated with more than 600 patients suffering from sleep disorders and and 1200 adults (Nielsen et al., 1999; 2003).
The HAD scale is an instrument that screens for anxiety and depressive disorders. It includes 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D). two scores (maximum score for each score = 21).
The patient is asked to write down in a notebook every morning the description of the dreams made during the night and to comment on it if necessary
Eligibility Criteria
Patients with COPD hospitalized in the respiratory and neuro-respiratory follow-up and rehabilitation department (SSR) of the Pitié-Salpêtrière Hospital. Healthy subjects without respiratory disorders selected to participate in the study.
You may qualify if:
- For both groups:
- Age ≥ 18 years
- Able to understand information and express non-opposition.
- Information and non-opposition gathered
- Affiliated with a social security system
- For patients:
- With confirmed COPD prior to hospitalization at the SRH
- Hospitalized at the SSR of the Pitié-Salpêtrière Hospital
You may not qualify if:
- For both groups:
- Patient under constraint
- Patient who cannot read or write French
- Patient under AME For healthy subjects
- Known respiratory pathology
- Obesity with BMI \> 35 kg/m².
- Known sleep apnea syndrome
- Smoking \> 30 PA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SSR Respiratory and Neuro Respiratory
Paris, 75013, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2022
First Posted
March 2, 2022
Study Start
July 1, 2022
Primary Completion
October 1, 2023
Study Completion
October 15, 2023
Last Updated
October 30, 2023
Record last verified: 2023-10